F S&P 500
5,526.25 -10.75 (-0.19%) F Dow Jones
39,424.00 -102.00 (-0.26%) F Nasdaq
19,942.50 -29.75 (-0.15%) E-mini Russell 2000 Index Futur
2,034.60 -10.30 (-0.50%) Petróleo
81.17 +0.34 (+0.42%) Oro
2,324.20 -6.60 (-0.28%)
AmeriCann, Inc. (ACAN)
AmeriCann, Inc.
1555 Blake Street
Unit 502
Denver, CO 80202
United States
303 862 9000
https://www.americann.co
Sector(es): Real Estate
Industria: Real Estate Services
Empleados a tiempo completo: 3
Ejecutivos clave
| Nombre | Título | Pagar | Ejecutado | Año de nacimiento |
|---|---|---|---|---|
| Mr. Timothy Ryan Keogh | CEO, President & Director | 180k | N/D | 1980 |
| Mr. Benjamin J. Barton | Founder, Chief Financial & Accounting Officer and Director | 180k | N/D | 1965 |
| Dr. Rien Havens Ph.D. | Extraction & Infused Product Advisor and Member of Advisory Board | N/D | N/D | N/D |
| Mr. Eric Forington | Genetics & Breeding Advisor and Member of Advisory Board | N/D | N/D | N/D |
| Dr. D. Michael Anderson | Medical Advisor & Member of Advisory Board | N/D | N/D | N/D |
| Mr. Nick Brait | Licensing & Compliance Advisor and Member of Advisory Board | N/D | N/D | N/D |
Descripción
AmeriCann, Inc. designs, develops, leases, and operates cannabis cultivation, processing, and manufacturing facilities in the United States. The company engages in the product manufacturing and greenhouse cultivation facilities for licensed cannabis business. Its flagship project is the Massachusetts Cannabis Center that is developed on a 52-acre parcel of land located in Freetown, southeastern Massachusetts. The company also provides medical cannabis and adult-use cannabis. The company was formerly known as Nevada Health Scan, Inc. and changed its name to AmeriCann, Inc. in 2014. AmeriCann, Inc. was incorporated in 2010 and is headquartered in Denver, Colorado.
Gestión corporativa
La calificación ISS Governance QuickScore de AmeriCann, Inc. a partir del N/D es N/D. Las puntuaciones principales son Auditoría: N/D; Junta: N/D; Derechos del accionista: N/D; Compensación: N/D.
